Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Teva Says U.S. FDA Approves Aerosol Treatment of Nasal Allergies

March 26 (Bloomberg) -- Teva Pharmaceutical Industries Ltd. said the U.S. Food and Drug Administration has approved its QNASL nasal aerosol for the treatment of nasal allergies. The product will be available by prescription in April 2012, Teva said in a Business Wire statement today.

Link to Statement:{NSN M1HS203V7UA6 <GO>}

Link to Company News:{3400398Z US <Equity> CN <GO>} Link to Company News:{TEVA IT <Equity> CN <GO>}

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at

To contact the editor responsible for this story: Gwen Ackerman at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.